Aldesleukin
- Level
- Commodity
- Parent
- 51333200
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51333201This classification denotes a therapeutic interleukin-2 with the molecular formula C690H1115N177O202S6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M89N0Q7EQR, more generally known as aldesleukin. European Medicines Agency schedules aldesleukin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05303MIG. The term ALDESLEUKIN is an International Non-Proprietary Name or INN. see WHO INN reference publication, Volume 5, no. 3 1991, list 31. Most nations schedule aldesleukin under HS 35040000 and SITC 59225. As of Q4 2014, ALDESLEUKIN remains the US FDA Preferred Term for this commodity. Aldesleukin bears US NLM identifiers UMLS ID C0218986 and NCI Concept Code C1498. SMILES: NONE.
Same parent
Under 51333200 · 2Activities that produce or sell this
KBLI · 8Inherited from family 51330000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.